Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: Insights-IPF registry

Respiratory Research

Volumn 18, Issue 1, 2017, Pages

  Kreuter, Michael ^a,x   Swigris, Jeff ^b   Pittrow, David ^c   Geier, Silke ^d   Klotsche, Jens ^e   Prasse, Antje ^f,g,x   Wirtz, Hubert ^h   Koschel, Dirk ⁱ   Andreas, Stefan ^j   Claussen, Martin ^k,x   Grohé, Christian ^l   Wilkens, Henrike ^m   Hagmeyer, Lars ⁿ   Skowasch, Dirk ^o   Meyer, Joachim F ^p   Kirschner, Joachim ^q   Gläser, Sven ^r,s   Herth, Felix J F ^a,x   Welte, Tobias ^f,x   Neurohr, Claus ^t,x   Schwaiblmair, Martin ^u   Held, Matthias ^v   Bahmer, Thomas ^k,x   Frankenberger, Marion ^t,w,x   Behr, Jürgen ^t,w,x   more..

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b DEPARTMENT OF MEDICINE   (United States)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^e DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^h UNIVERSITY HOSPITAL LEIPZIG   (Germany)

ⁱ Fachkrankenhaus Coswig   (Germany)

^j UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^k Zytologisches Labor   (Germany)

^l Klinik fur Pneumologie   (Germany)

^m SAARLAND UNIVERSITY   (Germany)

ⁿ Krankenhaus Bethanien Solingen   (Germany)

^o UNIVERSITY HOSPITAL BONN   (Germany)

^p Munich Municipal Hospital   (Germany)

^q Center for Internal Medical Studies CIMS   (Germany)

^r UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^s Vivantes Klinikum Spandau   (Germany)

^t LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^u KLINIKUM AUGSBURG   (Germany)

^v Missionsärztliche Klinik Würzburg Abteilung Innere Medizin   (Germany)

^w ASKLEPIOS FACHKLINIKEN MÜNCHEN GAUTING   (Germany)

^x German Center for Lung Research   (Germany)

more..

Author keywords

Cohort study; Idiopathic pulmonary fibrosis; Patient related outcomes; Psychometrics

Indexed keywords

AGE; AGED; ARTICLE; CLINICAL PRACTICE; COMORBIDITY; CPI INDEX; DISEASE DURATION; DISEASE REGISTRY; DISEASE SEVERITY; EUROQOL FIVE DIMENSIONAL QUESTIONNAIRE; FEMALE; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; GENDER AGE PHYSIOLOGY INDEX; GENERAL HEALTH STATUS ASSESSMENT; HOSPITALIZATION; HUMAN; LONG TERM CARE; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; OXYGEN THERAPY; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE ASSESSMENT; SCORING SYSTEM; SIX MINUTE WALK TEST; ST. GEORGE RESPIRATORY QUESTIONNAIRE; TREATMENT INDICATION; UCSD SHORTNESS OF BREATH QUESTIONNAIRE; VISUAL ANALOG SCALE; WORLD HEALTH ORGANIZATION 5 WELL BEING INDEX; FORCED EXPIRATORY VOLUME; LUNG; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PATHOPHYSIOLOGY; PATIENT-REPORTED OUTCOME; PROSPECTIVE STUDY; PSYCHOLOGY; PSYCHOMETRY; REGISTER; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SPIROMETRY; TIME FACTOR; VITAL CAPACITY; WALK TEST;

AGED; COMORBIDITY; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT REPORTED OUTCOME MEASURES; PROSPECTIVE STUDIES; PSYCHOMETRICS; QUALITY OF LIFE; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPIROMETRY; TIME FACTORS; VITAL CAPACITY; WALK TEST;

EID: 85023636186     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/s12931-017-0621-y     Document Type: Article

References (40)

1. Behr J, Kreuter M, Hoeper MM, Wirtz H, Klotsche J, Koschel D, Andreas S, Claussen M, Grohe C, Wilkens H, Randerath W, Skowasch D, Meyer FJ, Kirschner J, Glaser S, Herth FJ, Welte T, Huber RM, Neurohr C, Schwaiblmair M, Kohlhaufl M, Hoffken G, Held M, Koch A, Bahmer T, Pittrow D. Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry. Eur Respir J. 2015;46(1):186-96.
2. Raghu G, Rochwerg B, Zhang Y, Garcia CA, Azuma A, Behr J, Brozek JL, Collard HR, Cunningham W, Homma S, Johkoh T, Martinez FJ, Myers J, Protzko SL, Richeldi L, Rind D, Selman M, Theodore A, Wells AU, Hoogsteden H, Schunemann HJ. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192(2):e3-19.
3. Kreuter M, Ehlers-Tenenbaum S, Palmowski K, Bruhwyler J, Oltmanns U, Muley T, Heussel CP, Warth A, Kolb M, Herth FJ. Impact of comorbidities on mortality in patients with idiopathic pulmonary fibrosis. PLoS One. 2016;11(3):e0151425.
4. Olson AL, Swigris JJ, Lezotte DC, Norris JM, Wilson CG, Brown KK. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med. 2007;176(3):277-84.
5. Rochwerg B, Neupane B, Zhang Y, Garcia CC, Raghu G, Richeldi L, Brozek J, Beyene J, Schunemann H. Treatment of idiopathic pulmonary fibrosis: a network meta-analysis. BMC Med. 2016;14:18.
6. Canestaro WJ, Forrester SH, Raghu G, Ho L, Devine BE. Drug treatment of idiopathic pulmonary fibrosis: systematic review and network meta-analysis. Chest. 2016;149(3):756-66.
7. Swigris JJ, Han M, Vij R, Noth I, Eisenstein EL, Anstrom KJ, Brown KK, Fairclough D. The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis. Respir Med. 2012;106(10):1447-55.
8. Yount SE, Beaumont JL, Chen SY, Kaiser K, Wortman K, Van Brunt DL, Swigris J, Cella D. Health-related quality of life in patients with idiopathic pulmonary fibrosis. Lung. 2016;194(2):227-34.
9. Behr J, Hoeper MM, Kreuter M, Klotsche J, Wirtz H, Pittrow D. Characteristics and management of idiopathic pulmonary fibrosis: INSIGHTS-IPF registry. Dtsch Med Wochenschr. 2012;137(49):2586-8.
10. Behr J, Hoeper M, Kreuter M, Klotsche J, Wirtz H, Pittrow D. Investigating significant health trends in idiopathic pulmonary fibrosis (INSIGHTS-IPF): rationale, aims and design of a nationwide prospective registry. BMJ Open Respir Res. 2014;1:e000010. doi: 10.1136/bmjresp-2013-000010.
11. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schunemann HJ. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788-824.
12. Ries AL. Minimally clinically important difference for the UCSD shortness of breath questionnaire, borg scale, and visual analog scale. Copd. 2005;2(1):105-10.
13. Kupferberg DH, Kaplan RM, Slymen DJ, Ries AL. Minimal clinically important difference for the UCSD shortness of breath questionnaire. J Cardpulm Rehabil. 2005;25(6):370-7.
14. Jones PW, Quirk FH, Baveystock CM. The St George's respiratory questionnaire. Respir Med. 1991;85(Suppl B):25-31. discussion 33-27
15. Swigris JJ, Esser D, Conoscenti CS, Brown KK. The psychometric properties of the St George's respiratory questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review. Health Qual Life Outcomes. 2014;12:124.
16. Pickard AS, Neary MP, Cella D. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes. 2007;5:70.
17. Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, Poletti V, Buccioli M, Elicker BM, Jones KD, King TE Jr, Collard HR. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012;156(10):684-91.
18. Glaspole IN, Chapman SA, Cooper WA, Ellis SJ, Goh NS, Hopkins PM, Macansh S, Mahar A, Moodley YP, Paul E, Reynolds PN, Walters EH, Zappala CJ, Corte TJ. Health-related quality of life in idiopathic pulmonary fibrosis: data from the Australian IPF registry. Respirology. 2017;22(5):950-6.
19. Furukawa T, Taniguchi H, Ando M, Kondoh Y, Kataoka K, Nishiyama O, Johkoh T, Fukuoka J, Sakamoto K, Hasegawa Y. The St. George's respiratory questionnaire as a prognostic factor in IPF. Respir Res. 2017;18(1):18.
20. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR, Investigators IT. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2071-82.
21. Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Nathan SD, Wells AU, Collard HR, Costabel U, Richeldi L, de Andrade J, Khalil N, Morrison LD, Lederer DJ, Shao L, Li X, Pedersen PS, Montgomery AB, Chien JW, O'Riordan TG. Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. Ann Intern Med. 2013;158(9):641-9.
22. King TE Jr, Albera C, Bradford WZ, Costabel U, Hormel P, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, du Bois RM. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet. 2009;374(9685):222-8.
23. King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW, Group AS. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2083-92.
24. Verma G, Marras T, Chowdhury N, Singer L. Health-related quality of life and 6 min walk distance in patients with idiopathic pulmonary fibrosis. Can Respir J. 2011;18(5):283-7.
25. Han MK, Swigris J, Liu L, Bartholmai B, Murray S, Giardino N, Thompson B, Frederick M, Li D, Schwarz M, Limper A, Flaherty K, Martinez FJ. Gender influences health-related quality of life in IPF. Respir Med. 2010;104(5):724-30.
26. Chang JA, Curtis JR, Patrick DL, Raghu G. Assessment of health-related quality of life in patients with interstitial lung disease. Chest. 1999;116(5):1175-82.
27. Belkin A, Albright K, Swigris JJ. A qualitative study of informal caregivers' perspectives on the effects of idiopathic pulmonary fibrosis. BMJ Open Respir Res. 2014;1(1):e000007.
28. Yorke J, Jones PW, Swigris JJ. Development and validity testing of an IPF-specific version of the St George's respiratory questionnaire. Thorax. 2010;65(10):921-6.
29. Lechtzin N, Hilliard ME, Horton MR. Validation of the cough quality-of-life questionnaire in patients with idiopathic pulmonary fibrosis. Chest. 2013;143(6):1745-9.
30. Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Ogawa T, Watanabe F, Nishimura K. Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor? Respir Med. 2005;99(4):408-14.
31. Zimmermann CS, Carvalho CR, Silveira KR, Yamaguti WP, Moderno EV, Salge JM, Kairalla RA, Carvalho CR. Comparison of two questionnaires which measure the health-related quality of life of idiopathic pulmonary fibrosis patients. Braz J Med Biol Res. 2007;40(2):179-87.
32. Patel AS, Siegert RJ, Brignall K, Gordon P, Steer S, Desai SR, Maher TM, Renzoni EA, Wells AU, Higginson IJ, Birring SS. The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire. Thorax. 2012;67(9):804-10.
33. Kreuter M, Birring SS, Wijsenbeek M, Wapenaar M, Oltmanns U, Costabel U, Bonella F. German validation of the "King's Brief Interstitial Lung Disease (K-Bild) health status questionnaire". Pneumologie. 2016;70:742.
34. Peng S, Li Z, Kang J, Hou X. Cross-sectional and longitudinal construct validity of the Saint George's respiratory questionnaire in patients with IPF. Respirology. 2008;13(6):871-9.
35. Yorke J, Swigris J, Russell AM, Moosavi SH, Ng Man Kwong G, Longshaw M, Jones PW. Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease. Chest. 2011;139(1):159-64.
36. Olson AL, Brown KK, Swigris JJ. Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis. Patient Relat Outcome Meas. 2016;7:29-35.
37. Bajwah S, Ross JR, Peacock JL, Higginson IJ, Wells AU, Patel AS, Koffman J, Riley J. Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature. Thorax. 2013;68(9):867-79.
38. Zisman DA, Schwarz M, Anstrom KJ, Collard HR, Flaherty KR, Hunninghake GW. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med. 2010;363(7):620-8.
39. Yorke J, Spencer LG, Duck A, Ratcliffe S, Kwong GN, Longshaw MS, Belkin A, Swigris JJ. Cross-Atlantic modification and validation of the a tool to assess quality of life in idiopathic pulmonary fibrosis (ATAQ-IPF-cA). BMJ Open Respir Res. 2014;1(1):e000024.
40. Walsh, S; Maher, T; Kolb, M; Poletti, V; Nusser, R; Richeldi, L; Vancheri, C; Wilsher, Ma; Antoniou, K; Behr, J; Bendstrup, E; Brown, K; Calandriello, L; Corte, T; Cottin, V; Crestani, B; Flaherty, K; Glaspole, I; Grutters, J; Inoue, Y; Kokosi, M; Kondoh, Y; Kouranos, V; Kreuter, M; Johannson, K; Judge, E; Ley, B; Margaritopoulos, GA.; Martinez, F; Molina-Molina, M; Morais, A; Nunes, H; Raghu, G; Ryerson, C; Selman, M; Spagnolo, P; Taniguchi, H; Tomassetti, S; Valeyre, D; Wijsenbeek, M; Wuyts, W; Hansell, D; Wells, A. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study. Eur Resp J 2017. in press.